Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIT Margin: 2011-2012

Historic EBIT Margin for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -50.75%.

  • Sonoma Pharmaceuticals' EBIT Margin rose 6516.00% to -19.21% in Q4 2012 from the same period last year, while for Dec 2012 it was -22.35%, marking a year-over-year increase of 3043.00%. This contributed to the annual value of -50.75% for FY2012, which is 2620.00% up from last year.
  • Sonoma Pharmaceuticals' EBIT Margin amounted to -50.75% in FY2012, which was up 34.05% from -76.94% recorded in FY2011.
  • Over the past 5 years, Sonoma Pharmaceuticals' EBIT Margin peaked at -50.75% during FY2012, and registered a low of -76.94% during FY2011.
  • In the last 2 years, Sonoma Pharmaceuticals' EBIT Margin had a median value of -63.84% in 2011 and averaged -63.84%.
  • Data for Sonoma Pharmaceuticals' EBIT Margin shows a peak YoY skyrocketed of 2,620bps (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' EBIT Margin (Yearly) stood at -76.94% in 2011, then spiked by 2,620bps to -50.75% in 2012.